/
Comparison of US/EU  Biosimilar Comparison of US/EU  Biosimilar

Comparison of US/EU Biosimilar - PowerPoint Presentation

aaron
aaron . @aaron
Follow
350 views
Uploaded On 2018-12-26

Comparison of US/EU Biosimilar - PPT Presentation

Guidelines Kamali Chance MPH PhD RAC Senior Director Head Global Biosimilars Regulatory Strategy Definition of Biosimilarity Biosimilar Guidelines Issuance in the EU and US Regulation ID: 746229

reference product clinical biosimilar product reference biosimilar clinical biosimilars guidelines amp licensed act fda 505 approved sep approval safety

Share:

Link:

Embed:

Download Presentation from below link

Download Presentation The PPT/PDF document "Comparison of US/EU Biosimilar" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.


Presentation Transcript